title: Optimal management of DRESS syndrome in course of infectious endocarditis.
authors.forename: Emanuel
authors.initials: E
authors.lastname: Della-Torre
authors.forename: Mona-Rita
authors.initials: MR
authors.lastname: Yacoub
authors.forename: Patrizia
authors.initials: P
authors.lastname: Pignatti
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Della-Torre
authors.forename: Maria-Grazia
authors.initials: MG
authors.lastname: Sabbadini
authors.forename: Giselda
authors.initials: G
authors.lastname: Colombo
authors.forename: Moreno
authors.initials: M
authors.lastname: Tresoldi
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D003521:Cyclopropanes; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D004697:Endocarditis, Bacterial / Q000150:complications*; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013440:Sulfides; D013577:Syndrome; D016896:Treatment Outcome; D014640:Vancomycin / Q000009:adverse effects
chemical_list: D000085:Acetates; D000900:Anti-Bacterial Agents; D003521:Cyclopropanes; D016756:Immunoglobulins, Intravenous; D011804:Quinolines; D013440:Sulfides; D014640:Vancomycin; C093875:montelukast; D008775:Methylprednisolone